SGMT peer analysis
Sagimet Biosciences (SGMT) against its competitors: price, today's move, 1-year return and market value side by side.
SGMT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACHV Achieve Life Sciences | $6.77 | 0.74% | 34.89% | $685.63M |
| ARCT Arcturus | $9.51 | -8.12% | 19.21% | $293.15M |
| ASMB Assembly Biosciences | $21.74 | 6.46% | -36.41% | $415.76M |
| AVIR Atea Pharmaceuticals | $4.42 | 2.55% | 35.49% | $352.10M |
| FHTX Foghorn Therapeutics | $2.04 | 9.09% | -53.25% | $111.05M |
| HUMA Humacyte | $0.46 | 1.99% | -68.91% | $125.22M |
| IMRX Immuneering | $3.65 | -0.82% | -43.68% | $233.79M |
| TRDA Entrada Therapeutics | $4.69 | -4.19% | -29.54% | $191.45M |
| VYGR Voyager Therapeutics | $1.99 | 6.70% | -57.14% | $113.88M |
| ZURA Zura Bio | $1.19 | -70.90% | 12.12% | $392.04M |
| SGMT Sagimet Biosciences | $10.85 | 10.15% | 26.90% | $699.16M |
- SGMT's peers: ACHV (Achieve Life Sciences), ARCT (Arcturus), ASMB (Assembly Biosciences), AVIR (Atea Pharmaceuticals), FHTX (Foghorn Therapeutics), HUMA (Humacyte), IMRX (Immuneering), TRDA (Entrada Therapeutics).
Updated 2026-11-10 04:46 UTC